OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/06/2026
Back to search
Official data from USPTO
ACT TO IMPROVE LIFE PROVEPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
08/06/2026
Trademark type
Combined
Nice classes
1, 5
Filing date
11/08/2024
Registration date
10/21/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2025
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
33
Owner location
FR
Examiner
HUSSAIN, TASNEEM
Law office
M90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "PROVEPHARM" in dark blue with the letters "V" and "A" in light blue with the "A" missing the bar. The stylized wording "ACT TO IMPROVE LIFE" in light blue appears above "PHARM". An incomplete circle featuring various geometric shapes in various shades of light blue and dark blue starts above the letter "V" and continues below the "V" to the bottom of the letter "A".
Holders and representatives
Holders
PROVEPHARM LIFE SOLUTIONS
Representatives
Kaitlyn M. Garvin Saunders & Silverstein LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical products in the nature of chemicals for use in industry and science; raw methylene blue for scientific or research use; chemical additives for use in manufacture of pharmaceuticals; proteins in raw material form for scientific and medical research; proteins used in manufacturing processes; chemical additivesemulsifiersvitaminsantioxidantsadditivesemollients and proteins for manufacture of cosmetics; plant hormones being phytohormones; vitamins for manufacturing pharmaceutical products; stabilizing chemical agentsenzyme stabilizers for vitamins
Class 5
Clinical medical reagents; synthetic peptides for the treatment of blood poisoning for pharmaceutical use; medicines to treat conditions of the leghoofearnose and throat for animals; vitamins for animals; medicated foamsoilslotionscreamsbalmsointmentsgels and milks for the treatment of skin for pharmaceuticalmedical and veterinary use; phytotherapy preparations for medical use; vitamins and vitamin preparations; pharmaceutical diagnostic preparations for medical purposes for marking tissues by injection in surgery and in internal medicine; chemical productssurgical dyes for medical use for marking tissues by injection in surgery and in internal medicine; injectable pharmaceutical solutions for use as radio-isotope markers for diagnostic use in surgical procedures; drug delivery agents in the form of vials in the nature of ampoules sold filled with injectable pharmaceutical solutions that facilitate delivery of pharmaceutical preparations; pre-filled syringes sold filled with antidotes for medical and clinical use and sold filled with injectable pharmaceuticalsurgical dyes for marking tissues by application in surgery and internal medicine; methylene blue to treat methemoglobinemia for medical use; methylene blue solutionssurgical dyes for medical use; indigo carminesurgical dyes for medical use; indigo cumin solutionssurgical dyes for medical use
Publications
History of USPTO decisions and trademark events.
26 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/20/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/19/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/21/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/01/2026
FIMP
FINAL DISPOSITION PROCESSED
05/01/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/21/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/21/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/21/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/02/2025
PUBO
PUBLISHED FOR OPPOSITION
09/02/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/27/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/29/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/08/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/08/2025
RFNT
REFUSAL PROCESSED BY IB
07/05/2025
ALIE
ASSIGNED TO LIE
06/23/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/14/2025
RFRR
REFUSAL PROCESSED BY MPU
06/14/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/15/2025
CNRT
NON-FINAL ACTION WRITTEN
04/14/2025
DOCK
ASSIGNED TO EXAMINER
04/09/2025
MAFR
APPLICATION FILING RECEIPT MAILED
02/28/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/28/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/20/2025
Continuous trademark protection
Get notified about every new filing that threatens ACT TO IMPROVE LIFE PROVEPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.